Drug safety evaluation : (Record no. 653502)

MARC details
000 -LEADER
fixed length control field 08156cam a2200937 i 4500
001 - CONTROL NUMBER
control field ocn995850704
003 - CONTROL NUMBER IDENTIFIER
control field OCoLC
005 - DATE AND TIME OF LATEST TRANSACTION
control field 20250702170809.0
006 - FIXED-LENGTH DATA ELEMENTS--ADDITIONAL MATERIAL CHARACTERISTICS
fixed length control field m o d
007 - PHYSICAL DESCRIPTION FIXED FIELD--GENERAL INFORMATION
fixed length control field cr nn||||mamaa
008 - FIXED-LENGTH DATA ELEMENTS--GENERAL INFORMATION
fixed length control field 170731s2017 nyua ob 001 0 eng d
040 ## - CATALOGING SOURCE
Original cataloging agency RML
Language of cataloging eng
Description conventions pn
Transcribing agency RML
Modifying agency RML
-- OCLCO
-- GW5XE
-- SCB
-- YDX
-- UAB
-- OCLCO
-- OCLCF
-- STF
-- AZU
-- COO
-- OCLCO
-- TFH
-- OCLCO
-- OCLCA
-- BUF
-- OCLCO
-- CAUOI
-- OCLCO
-- VT2
-- UWO
-- OCLCO
-- OCLCQ
-- MERER
-- OCLCQ
-- U3W
-- UKMGB
-- OCLCA
-- OCLCO
-- OCLCQ
-- OCLCO
-- OCLCQ
-- OCLCA
-- OCLCO
-- OCLCQ
-- OCLCO
-- WSU
-- OCLCL
-- OCLCQ
-- UKAHL
-- EBLCP
-- OCLCO
-- OCLCQ
015 ## - NATIONAL BIBLIOGRAPHY NUMBER
National bibliography number GBB8M4913
Source bnb
016 7# - NATIONAL BIBLIOGRAPHIC AGENCY CONTROL NUMBER
Record control number 101717472
Source DNLM
016 7# - NATIONAL BIBLIOGRAPHIC AGENCY CONTROL NUMBER
Record control number 019140456
Source Uk
019 ## -
-- 999589244
-- 1005003893
-- 1021278560
-- 1048127083
-- 1079338533
-- 1081224281
020 ## - INTERNATIONAL STANDARD BOOK NUMBER
International Standard Book Number 9781493971725
Qualifying information (electronic bk.)
020 ## - INTERNATIONAL STANDARD BOOK NUMBER
International Standard Book Number 1493971727
Qualifying information (electronic bk.)
020 ## - INTERNATIONAL STANDARD BOOK NUMBER
Canceled/invalid ISBN 9781493971701
Qualifying information (print)
020 ## - INTERNATIONAL STANDARD BOOK NUMBER
Canceled/invalid ISBN 1493971700
024 7# - OTHER STANDARD IDENTIFIER
Standard number or code 10.1007/978-1-4939-7172-5
Source of number or code doi
029 1# - (OCLC)
OCLC library identifier AU@
System control number 000061156516
029 1# - (OCLC)
OCLC library identifier UKMGB
System control number 019140456
035 ## - SYSTEM CONTROL NUMBER
System control number (OCoLC)995850704
Canceled/invalid control number (OCoLC)999589244
-- (OCoLC)1005003893
-- (OCoLC)1021278560
-- (OCoLC)1048127083
-- (OCoLC)1079338533
-- (OCoLC)1081224281
037 ## - SOURCE OF ACQUISITION
Stock number com.springer.onix.9781493971725
Source of stock number/acquisition Springer Nature
050 #4 - LIBRARY OF CONGRESS CALL NUMBER
Classification number RA1238
060 #4 - NATIONAL LIBRARY OF MEDICINE CALL NUMBER
Classification number W1
Item number ME9616J v.1641 2017
060 #4 - NATIONAL LIBRARY OF MEDICINE CALL NUMBER
Classification number QV 771
072 #7 - SUBJECT CATEGORY CODE
Subject category code MMG
Source bicssc
072 #7 - SUBJECT CATEGORY CODE
Subject category code MED071000
Source bisacsh
082 04 - DEWEY DECIMAL CLASSIFICATION NUMBER
Classification number 615.7/04
Edition number 23
049 ## - LOCAL HOLDINGS (OCLC)
Holding library MAIN
245 00 - TITLE STATEMENT
Title Drug safety evaluation :
Remainder of title methods and protocols /
Statement of responsibility, etc. Jean-Charles Gautier.
250 ## - EDITION STATEMENT
Edition statement Second edition
264 #1 - PRODUCTION, PUBLICATION, DISTRIBUTION, MANUFACTURE, AND COPYRIGHT NOTICE
Place of production, publication, distribution, manufacture New York :
Name of producer, publisher, distributor, manufacturer Humana Press :
-- Springer,
Date of production, publication, distribution, manufacture, or copyright notice ©2017.
300 ## - PHYSICAL DESCRIPTION
Extent 1 online resource (xi, 427 pages) :
Other physical details illustrations (some color)
336 ## - CONTENT TYPE
Content type term text
Content type code txt
Source rdacontent
337 ## - MEDIA TYPE
Media type term computer
Media type code c
Source rdamedia
338 ## - CARRIER TYPE
Carrier type term online resource
Carrier type code cr
Source rdacarrier
347 ## - DIGITAL FILE CHARACTERISTICS
File type text file
Encoding format PDF
Source rda
490 1# - SERIES STATEMENT
Series statement Methods in molecular biology,
International Standard Serial Number 1940-6029 ;
Volume/sequential designation volume no. 1641
504 ## - BIBLIOGRAPHY, ETC. NOTE
Bibliography, etc Includes bibliographical references and index.
505 00 - FORMATTED CONTENTS NOTE
Title Nonclinical development of combination drugs /
Statement of responsibility Alberto Lodola --
Title Juvenile nonclinical safety studies in support of pediatric drug development /
Statement of responsibility Paul C. Barrow and Georg Schmitt --
Title Procedures of necropsy and tissue sampling /
Statement of responsibility Laurence Fiette, Mohamed Slaoui, and Anne-Laure Bauchet --
Title Tissue sampling and processing for histopathology evaluation /
Statement of responsibility Mohamed Slaoui, Anne-Laure Bauchet, and Laurence Fiette --
Title Principles and methods of immunohistochemistry /
Statement of responsibility José A. Ramos-Vara --
Title Applications of mass spectrometry imaging for safety evaluation /
Statement of responsibility David Bonnel and Jonathan Stauber Part III Genetic Toxicology --
Title In vivo rat T-lymphocyte Pig-a assay : detection and expansion of cells deficient in the GPI-anchored CD48 surface marker for analysis of mutation in the endogenous Pig-a gene /
Statement of responsibility Vasily N. Dobrovolsky, Javier Revollo, Dayton M. Petibone, and Robert H. Heflich --
Title Detection of in vivo mutation in the Pig-a gene of mouse bone marrow erythroids /
Statement of responsibility Takafumi Kimoto and Daishiro Miura --
Title Use of bacterial repair endonucleases in the comet assay /
Statement of responsibility Andrew R. Collins --
Title Automated patch-clamp methods for the hERG cardiac potassium channel /
Statement of responsibility Sylvie Houtmann, Brigitte Schombert, Camille Sanson, Michel Partiseti, and G. Andrees Bohme --
Title Impedance measurement in induced pluripotent stem cell-derived cardiomyocytes /
Statement of responsibility Emma-Jane Poulton --
Title Target safety assessment : strategies and resources /
Statement of responsibility Richard J. Brennan --
Title NMR and MS methods for metabolomics /
Statement of responsibility Alexander Amberg, Björn Riefke, Götz Schlotterbeck, Alfred Ross, Hans Senn, Frank Dieterle, and Matthias Keck --
Title Protocols and applications of cellular metabolomics in safety studies using precision-cut tissue slices and carbon 13 NMR /
Statement of responsibility Gabriel Baverel, Maha El Hage, and Guy Martin --
Title Statistical analysis of auantitative RT-PCR results /
Statement of responsibility Richard Khan-Malek and Ying Wang --
Title Evaluation of mitochondrial respiration in cultured rat hepatocytes /
Statement of responsibility Jean-Pierre Marchandeau and Gilles Labbe --
Title FETAX assay for evaluation of developmental toxicity /
Statement of responsibility Isabelle Mouche, Laure Malésic, and Olivier Gillardeaux --
Title Evaluation of embryotoxicity using the Zebrafish model /
Statement of responsibility Lisa Truong and Robert L. Tanguay --
Title Absolute quantification of toxicological biomarkers via mass spectrometry /
Statement of responsibility Thomas Y.K. Lau, Ben C. Collins, Peter Stone, Ning Tang, William M. Gallagher, and Stephen R. Pennington --
Title Next-generation sequencing to investigate urinary microRNAs from Macaca fascicularis (cynomolgus monkey) /
Statement of responsibility Yaligara Veeranagouda, Jean-François Léonard, Jean-Charles Gautier, and Eric Boitier --
Title Quantitative RT-PCR for microRNAs in biofluids /
Statement of responsibility Michael Thorsen, Thorarinn Blondal, and Peter Mouritzen --
Title Chromogenic in situ hybridization methods for microRNA biomarker monitoring of drug safety and efficacy /
Statement of responsibility Barbara R. Gould, Tina Damgaard, and Boye Schnack Nielsen --
Title Urine exosome isolation and characterization /
Statement of responsibility Jonathan M. Street, Erik H. Koritzinsky, Deonna M. Glispie, and Peter S.T. Yuen.
588 0# - SOURCE OF DESCRIPTION NOTE
Source of description note Online resource; title from PDF title page (SpringerLink, viewed July 31, 2017).
520 ## - SUMMARY, ETC.
Summary, etc. This second edition provides up-to-date chapters and new chapters focusing on the most recent advances in the field of drug safety evaluation. Divided into seven parts, chapters detail specific aspects related to the experimental design of preclinical studies conducted to support the safety of pediatric and combination drugs, necropsy and histopathology evaluation, mass spectrometry imaging, genetic toxicology protocols including the Pig-a mutation assay, safety pharmacology methods such as automatization of patch-clamp procedures, target safety assessment for investigative toxicology, screening assays for developmental toxicology, and methods to characterize novel translational safety biomarkers like microRNAs. Written in the highly successful Methods in Molecular Biology series format, chapters include introductions to their respective topics, lists of the necessary materials and reagents, step-by-step, readily reproducible laboratory protocols, and tips on troubleshooting to avoid known pitfalls. Authoritative and practical, Drug Safety Evaluation: Methods and Protocols, Second Edition aims to ensure successful results in the further study of this vital field.
650 #0 - SUBJECT ADDED ENTRY--TOPICAL TERM
Topical term or geographic name as entry element Drugs
General subdivision Toxicology.
9 (RLIN) 86066
650 #0 - SUBJECT ADDED ENTRY--TOPICAL TERM
Topical term or geographic name as entry element Drugs
General subdivision Testing.
9 (RLIN) 82056
650 #0 - SUBJECT ADDED ENTRY--TOPICAL TERM
Topical term or geographic name as entry element Poisoning.
9 (RLIN) 86892
650 #0 - SUBJECT ADDED ENTRY--TOPICAL TERM
Topical term or geographic name as entry element Drugs
General subdivision Side effects.
9 (RLIN) 107113
650 #2 - SUBJECT ADDED ENTRY--TOPICAL TERM
Topical term or geographic name as entry element Evaluation Studies as Topic
9 (RLIN) 30855
650 #2 - SUBJECT ADDED ENTRY--TOPICAL TERM
Topical term or geographic name as entry element Poisoning
9 (RLIN) 86892
650 #2 - SUBJECT ADDED ENTRY--TOPICAL TERM
Topical term or geographic name as entry element Investigative Techniques
Authority record control number (DNLM)D008919
9 (RLIN) 12500
650 #2 - SUBJECT ADDED ENTRY--TOPICAL TERM
Topical term or geographic name as entry element Drug Discovery
General subdivision methods
9 (RLIN) 86383
650 #2 - SUBJECT ADDED ENTRY--TOPICAL TERM
Topical term or geographic name as entry element Substance-Related Disorders
9 (RLIN) 4914
650 #2 - SUBJECT ADDED ENTRY--TOPICAL TERM
Topical term or geographic name as entry element Drug Evaluation, Preclinical
General subdivision methods
9 (RLIN) 80630
650 #2 - SUBJECT ADDED ENTRY--TOPICAL TERM
Topical term or geographic name as entry element Drug-Related Side Effects and Adverse Reactions
9 (RLIN) 86893
650 #2 - SUBJECT ADDED ENTRY--TOPICAL TERM
Topical term or geographic name as entry element Toxicity Tests
9 (RLIN) 80294
650 #6 - SUBJECT ADDED ENTRY--TOPICAL TERM
Topical term or geographic name as entry element Médicaments
General subdivision Toxicologie.
9 (RLIN) 114984
650 #6 - SUBJECT ADDED ENTRY--TOPICAL TERM
Topical term or geographic name as entry element Médicaments
General subdivision Essais cliniques.
9 (RLIN) 105682
650 #6 - SUBJECT ADDED ENTRY--TOPICAL TERM
Topical term or geographic name as entry element Intoxication.
9 (RLIN) 107046
650 #6 - SUBJECT ADDED ENTRY--TOPICAL TERM
Topical term or geographic name as entry element Toxicomanie.
9 (RLIN) 186828
650 #6 - SUBJECT ADDED ENTRY--TOPICAL TERM
Topical term or geographic name as entry element Médicaments
General subdivision Effets secondaires.
9 (RLIN) 970528
650 #7 - SUBJECT ADDED ENTRY--TOPICAL TERM
Topical term or geographic name as entry element Pharmacology.
Source of heading or term bicssc
9 (RLIN) 5990
650 #7 - SUBJECT ADDED ENTRY--TOPICAL TERM
Topical term or geographic name as entry element Medical
General subdivision Pharmacology.
Source of heading or term bisacsh
9 (RLIN) 80262
650 #7 - SUBJECT ADDED ENTRY--TOPICAL TERM
Topical term or geographic name as entry element Drugs
General subdivision Testing
Source of heading or term fast
9 (RLIN) 82056
650 #7 - SUBJECT ADDED ENTRY--TOPICAL TERM
Topical term or geographic name as entry element Drugs
General subdivision Toxicology
Source of heading or term fast
9 (RLIN) 86066
655 #0 - INDEX TERM--GENRE/FORM
Genre/form data or focus term Electronic books.
9 (RLIN) 396
655 #2 - INDEX TERM--GENRE/FORM
Genre/form data or focus term Laboratory Manual
655 #7 - INDEX TERM--GENRE/FORM
Genre/form data or focus term Laboratory manuals
Source of term fast
655 #7 - INDEX TERM--GENRE/FORM
Genre/form data or focus term Laboratory manuals.
Source of term lcgft
655 #7 - INDEX TERM--GENRE/FORM
Genre/form data or focus term Manuels de laboratoire.
Source of term rvmgf
9 (RLIN) 966128
700 1# - ADDED ENTRY--PERSONAL NAME
Personal name Gautier, Jean-Charles,
Relator term editor.
9 (RLIN) 86894
758 ## -
-- has work:
-- Drug safety evaluation (Text)
-- https://id.oclc.org/worldcat/entity/E39PCFtfBh8WhFrFhBw7XBDFyq
-- https://id.oclc.org/worldcat/ontology/hasWork
776 08 - ADDITIONAL PHYSICAL FORM ENTRY
Relationship information Print version:
Title Drug safety evaluation.
International Standard Book Number 9781493971701
830 #0 - SERIES ADDED ENTRY--UNIFORM TITLE
Uniform title Methods in molecular biology (Clifton, N.J.) ;
Volume number/sequential designation v. 1641.
International Standard Serial Number 1064-3745
856 40 - ELECTRONIC LOCATION AND ACCESS
Uniform Resource Identifier <a href="https://link-springer-com.libraryproxy.ist.ac.at/10.1007/978-1-4939-7172-5">https://link-springer-com.libraryproxy.ist.ac.at/10.1007/978-1-4939-7172-5</a>
938 ## -
-- ProQuest Ebook Central
-- EBLB
-- EBL31097764
938 ## -
-- Askews and Holts Library Services
-- ASKH
-- AH35661734
938 ## -
-- YBP Library Services
-- YANK
-- 14735180
994 ## -
-- 92
-- ATIST
Holdings
Withdrawn status Lost status Damaged status Not for loan Collection code Home library Current library Date acquired Total Checkouts Date last seen Price effective from Koha item type
  Not Lost     eBook Protocols e-Library e-Library 03/08/2022   03/08/2022 03/08/2022 eBook

Powered by Koha